PATENTS ACT
The Indian Drug Manufacturers' Association (idma) has moved the Bombay High Court challenging various issues laid down in the amendments to the 1972 Patent Rules. The government had, in early June, notified the amendments to the Patent Rules following the enactment of the Patents (Amendment) Act, 1999. The petition, it is believed, challenges various "objectionable' clauses laid down in the rules. The drug body claims that the amended rules go much beyond the TRIPS requirements and even supercede the basic Patents (Amendment) Act, 1999.
Related Content
- Guidelines for promotion of research and innovation in start-ups and MSMEs in mining, mineral processing, metallurgy and recycling sector (S&T-PRISM)
- Order of the High Court of Kerala regarding pricing of breast cancer medicines, 02/11/2023
- Draft Patents (Amendment), Rules, 2023
- The Biological Diversity (Amendment) Bill, 2023
- Plastic waste in road construction- a path worth paving?: application of dry process in South Asia
- Order of the National Green Tribunal regarding unscientific dumping of solid waste near Meerut Hapur road, Uttar Pradesh, 09/05/2023